With support from the NIH Common Fund in 2015 and as part of the NIH Regenerative Medicine Program, NCATS opened the Stem Cell Translation Laboratory (SCTL) in 2017 with innovative laboratory technologies featuring advanced equipment and resources not available to most laboratories. The focus of the SCTL is to bring iPSC-derived cells closer to clinical applications and serve as a reference center for iPSC research and application. The original goals for the SCTL include:
Recently acquired equipment includes:
Want to join our team? Learn more about current job opportunities at the SCTL.